Received Oct 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Y015760 | OT |
This case is for GARDASIL-9 administration after the temperature excursion for lot y015760 02/10/2027 for the second patient.; No additional AE; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) injection (valid lot #Y015760, expiration date: 10-Feb-2027), 0.5 mL administered by intramuscular route for prophylaxis, which underwent temperature excursion of 47.7 F for 12 minutes, previous temperature excursion included 46.8 F for 5 minutes; 47.1 F for 9 minutes; 46.6 F for 4 minutes (product storage error). No symptoms reported. No further information was provided during the call. No additional adverse event (AE) was reported. This is one of the 5 reports from the same reporter.